Story detail view · 2026-07
STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

Quick Summary

Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.

Continue Reading on STAT News

Get instant updates on Telegram

Join our channel to receive the latest headlines and breaking stories as soon as they are published.

Join channel

Comments (0)

Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.

No comments yet. Be the first to share your thoughts!

Write a comment

0 / 500